|
|
Volumn 44, Issue 2, 2006, Pages 205-206
|
|
Molecular therapy for HCC?;Der einzug molekularer therapien beim HCC?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
ERLOTINIB;
PROTEIN TYROSINE KINASE INHIBITOR;
TRANSFORMING GROWTH FACTOR ALPHA;
ADULT;
AGED;
BLOOD TOXICITY;
CANCER IMMUNOTHERAPY;
CANCER SURGERY;
CHEMOEMBOLIZATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HYPOPHOSPHATEMIA;
LIVER CELL CARCINOMA;
LIVER TRANSPLANTATION;
MALE;
MOLECULAR BIOLOGY;
NOTE;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
|
|
EID: 33644607925
PISSN: 00442771
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2005-859031 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
